News Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
894 ^USD	-0.80%		-2.86%	+1.79%

Apr. 17	UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating	MT
Apr. 17	The market is pinning its hopes on earnings reports

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

The Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors	Apr. 17	BU
UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating	Apr. 17	MT
The market is pinning its hopes on earnings reports	Apr. 17
ANALYST RECOMMENDATIONS : Las Vegas Sands, Regeneron, Kinder Morgan, Rivian, Royal Caribbean...	Apr. 17
Regeneron to defend against DOJ complaint on drug-price manipulation	Apr. 15	RE
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation	Apr. 15	RE
Regeneron Pharmaceuticals : Statement on Department of Justice Filing Related to EYLEA® (aflibercept) Injection 2 mg	Apr. 15	PU
Goldman Sachs Adjusts Regeneron Pharmaceuticals Price Target to $1,126 From $1,121, Buy Rating Kept	Apr. 15	MT
Global markets live: Airbus, UBS, KKR, Meta Platforms, Tesla...	Apr. 11
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	Apr. 11	MT
Will there be any Fed rate cuts this year?	Apr. 11
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	Apr. 11	DJ
News Highlights : Top Company News of the Day - Thursday at 5 AM ET	Apr. 11	DJ
News Highlights : Top Company News of the Day - Thursday at 3 AM ET	Apr. 11	DJ
News Highlights : Top Company News of the Day - Thursday at 1 AM ET	Apr. 11	DJ
News Highlights : Top Company News of the Day - Wednesday at 11 PM ET	Apr. 10	DJ
News Highlights : Top Company News of the Day - Wednesday at 9 PM ET	Apr. 10	DJ
US DOJ Files Complaint Against Regeneron Pharmaceuticals for Alleged Fraudulent Drug Price Reporting	Apr. 10	MT
News Highlights : Top Company News of the Day - Wednesday at 7 PM ET	Apr. 10	DJ
US DOJ Files Complaint Against Regeneron Pharmaceuticals for Alleged Fraudulent Drug Price Reporting	Apr. 10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Summary

Filters